Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 12:10 PM ET | Feedback | Site Changes | Help
A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.
View All Commentary (HNAB)
Recs
greenie001 (60.48) Submitted: 2/22/07 10:38 AM : Start Price: $5.03 HNAB Score: -62.09
Oversold
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK